| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 2, 2025 | AMRX Amneal Pharmaceuticals, Inc. | Patel Gautam | Director | Sell | 17,410 | $8.01 | $139,454.10 | -0.8% | +5.3% | +63.1% | |
| Jan 2, 2025 | ETST Earth Science Tech, Inc. | Sanchez Yovan Arturo | Director | Buy | 56,151 | $0.12 | $6,738.12 | +4.2% | - | - | |
| Jan 2, 2025 | RMTI Rockwell Medical, Inc. | Chole Timothy73 | SVP, Chief Commercial Officer | Sell | 1,001 | $2.05 | $2,052.05 | -1.8% | -49.5% | -61.1% | |
| Dec 31, 2024 | CGC Canopy Growth Corp | Kruh Willy74 | Director | Sell | 2,004 | $2.67 | $5,350.68 | -15.1% | -66.8% | -58.4% | |
| Dec 31, 2024 | CGC Canopy Growth Corp | Mongeau Luc79 | Director | Sell | 2,004 | $2.67 | $5,350.68 | -15.1% | -66.8% | -58.4% | |
| Dec 31, 2024 | GTBIF Green Thumb Industries Inc. | Kravitz Bret | General Counsel And Secretary | Sell | 3,000 | $7.85 | $23,550.00 | -0.4% | - | - | |
| Dec 31, 2024 | NBIX Neurocrine Biosciences Inc | Delaet Ingrid67 | Chief Regulatory Officer | Sell | 272 | $138.10 | $37,563.20 | -9.8% | -19.0% | +3.9% | |
| Dec 31, 2024 | CGC Canopy Growth Corp | Lazzarato David Angelo75 | Director | Sell | 3,006 | $2.67 | $8,026.02 | -10.4% | -66.8% | -58.4% | |
| Dec 31, 2024 | CGC Canopy Growth Corp | Yanofsky Theresa75 | Director | Sell | 1,996 | $2.67 | $5,329.32 | -8.2% | -66.8% | -58.4% | |
| Dec 30, 2024 | UTHR United Therapeutics Corp | Benkowitz Michael47 | President And COO | Sell | 10,000 | $356.68 | $3,566,800.25 | -43.4% | -13.8% | +38.7% | |
| Dec 30, 2024 | UTHR United Therapeutics Corp | Mesa Nilda47 | Director | Sell | 255 | $355.77 | $90,720.10 | -4.4% | -13.8% | +38.7% | |
| Dec 26, 2024 | HIMS Hims & Hers Health, Inc. | Okupe Oluyemi55 | Chief Financial Officer | Sell | 4,213 | $29.98 | $126,317.96 | -3.2% | +17.1% | +20.4% | |
| Dec 24, 2024 | HIMS Hims & Hers Health, Inc. | Chi Michael | Chief Commercial Officer | Sell | 17,303 | $27.97 | $483,964.91 | -8.2% | +32.9% | +23.2% | |
| Dec 23, 2024 | GTBIF Green Thumb Industries Inc. | Nadelmann Ethan | Director | Buy | 632 | $7.91 | $4,995.96 | +2.1% | - | - | |
| Dec 23, 2024 | EOLS Evolus, Inc. | Beaver Sandra67 | Chief Financial Officer | Sell | 1,586 | $10.85 | $17,211.11 | -1.1% | +19.9% | -37.2% | |
| Dec 23, 2024 | EOLS Evolus, Inc. | Avelar Rui67 | See Remarks | Sell | 2,252 | $10.85 | $24,438.48 | -0.6% | +19.9% | -37.2% | |
| Dec 23, 2024 | EOLS Evolus, Inc. | Moatazedi David67 | See Remarks | Sell | 10,502 | $10.85 | $113,966.65 | -2.0% | +19.9% | -37.2% | |
| Dec 23, 2024 | UTHR United Therapeutics Corp | Benkowitz Michael47 | President And COO | Sell | 10,000 | $361.95 | $3,619,535.02 | -22.3% | -12.0% | +40.4% | |
| Dec 20, 2024 | HIMS Hims & Hers Health, Inc. | Okupe Oluyemi55 | Chief Financial Officer | Sell | 18,959 | $25.77 | $488,530.89 | -3.3% | +25.5% | +35.7% | |
| Dec 20, 2024 | TEVA Teva Pharmaceutical Industries Ltd | Mignone Roberto | Director | Sell | 286,000 | $22.01 | $6,294,030.60 | -29.2% | -26.5% | +37.4% | |
| Dec 20, 2024 | CPIX Cumberland Pharmaceuticals Inc | Young Caroline52 | Director | Buy | 154 | $1.66 | $256.15 | - | +115.0% | +94.3% | |
| Dec 20, 2024 | CPIX Cumberland Pharmaceuticals Inc | Kazimi A J59 | Chairman And CEO | Buy | 769 | $1.71 | $1,317.81 | - | +115.0% | +94.3% | |
| Dec 20, 2024 | CPIX Cumberland Pharmaceuticals Inc | Krogulski Kenneth54 | Director | Buy | 4,716 | $1.74 | $8,209.40 | +0.1% | +115.0% | +94.3% | |
| Dec 20, 2024 | CPIX Cumberland Pharmaceuticals Inc | Jones James53 | Director | Buy | 769 | $1.71 | $1,317.81 | +0.1% | +115.0% | +94.3% | |
| Dec 19, 2024 | HIMS Hims & Hers Health, Inc. | Chi Michael | Chief Commercial Officer | Sell | 7,500 | $26.00 | $195,000.00 | -3.7% | +28.5% | +34.9% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.